RSS
Ben van der Schaaf
A model fund? Five-step guide to explore possible funding for lower-priority drug trials
In this article, Ben van der Schaaf, principal at Arthur D. Little, gives a five-step guide to explore possible funding partnerships for lower-priority drug trials — a new model for big pharma. more